DIGITAL ULCERATION FOLLOWING GEMCITABIN PLUS CISPLATIN CHEMOTHERAPY IN A SYSTEMIC SCLEROSIS PATIENT WITH LUNG ADENOCARCINOMA
- 31 October 2024
- journal article
- Published by Caleo in Rheumatology Quarterly
- Vol. 2 (3) , 144-146
Abstract
Systemic sclerosis (SSc) is a systemic autoimmune disease characterized by fibrosis and vascular dysfunction in the skin and visceral organ systems. Digital ulceration is one of the major cause of morbidity. Although its pathogenesis has not been fully elucidated, structural and functional disturbances in small vessels are considered one of the major mechanisms. While cold exposure is considered the most important inciting factor for the development of digital ulceration, drugs and physical trauma are other described triggering factors. Herein, we report a case with SSc diagnosis who developed digital ulcers following gemcitabine and cisplatin chemotherapy for lung adenocarcinoma.Keywords
This publication has 4 references indexed in Scilit:
- Systemic sclerosisThe Lancet, 2022
- Current Concepts on the Pathogenesis of Systemic SclerosisClinical Reviews in Allergy & Immunology, 2021
- Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic AdenocarcinomaJournal of Pancreatic Cancer, 2017
- Gemcitabine: vascular toxicity and prothrombotic potentialExpert Opinion on Drug Safety, 2008